United States: Fourth Circuit Affirms Dismissal Of Putative Class Action Against Biopharmaceutical Company For Failure To Allege Scienter And Materiality - Shearman & Sterling LLP
The Company specialized in assisting biopharmaceutical companies conduct clinical trials as part of the Food and Drug Administration's approval process.
Full Article